The primary objective of this study was to determine the correlation between elevated levels of the CA 11-19 tumor marker in blood and the presence of colorectal cancer or pre-cancer.
- US Capital Global Securities Launches $5 Million Equity Investment in Advanced Medical Device Company
- Two more solid announcements from EDP Biotech
- EDP BioTech’s Eric Mayer back from “InnoSTARS” finals in China
- Seeking Alpha: Augury Investments discusses Exact Sciences and EDP Biotech
- One Knoxville company wins, another competing in InnoSTARS China event